BenevolentAI Investor Day Presentation Deck
Benefits from our technology approach
DISEASE-AGNOSTIC
go
Enabled by: a focus on breadth of biomedical
information and the integration of diverse,
wide-ranging data types.
ACCELERATES DISCOVERY
Enabled by: supporting scientists with
aggregated, summarised information and
tools to support efficient decisions
MODALITY-AGNOSTIC
S
Enabled by: early Target ID tools supporting
both small molecule and biologics
approaches.
SCALABLE & REPEATABLE
2
Enabled by: workflows and software
foundations designed for scale, run
repeatedly for internal deployment and
external collaborators.
NOVEL TARGET
Enabled by: large volumes of integrated data
can surface novel targets never considered
before and spark creativity in scientists.
POTENTIAL TO INCREASE
PROBABILITY OF SUCCESS
ஊ
Enabled by: tools enabling early data-driven
decisions to progress only the most
promising hypotheses.
Benevolent 38View entire presentation